Method of prophlactically treating infection using a recombinant fibrinogen binding protein clumping factor A (ClfA) or fragment thereof
US-9353160-B2 · May 31, 2016 · US
This page is not indexed by search engines while we improve data quality.
Geoghegan Joan — Human Necessities
Geoghegan Joan holds 1 patent in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Geoghegan Joan |
| Technology | Human Necessities |
| Patents in slice | 1 |
| Recent patents in slice | 0 |
| First year | 2016 |
| Last year | 2016 |
Representative patents
Notable publications linking Geoghegan Joan to Human Necessities.
Method of prophlactically treating infection using a recombinant fibrinogen binding protein clumping factor A (ClfA) or fragment thereof
US-9353160-B2 · May 31, 2016 · US
Method of prophlactically treating infection using a recombinant fibrinogen binding protein clumping factor A (ClfA) or fragment thereof
US-9353160-B2 · May 31, 2016 · US
Method of prophlactically treating infection using a recombinant fibrinogen binding protein clumping factor A (ClfA) or fragment thereof
US-9353160-B2 · May 31, 2016 · US
Method of prophlactically treating infection using a recombinant fibrinogen binding protein clumping factor A (ClfA) or fragment thereof
US-9353160-B2 · May 31, 2016 · US
Recent filings
Latest patents from Geoghegan Joan in Human Necessities.
Method of prophlactically treating infection using a recombinant fibrinogen binding protein clumping factor A (ClfA) or fragment thereof
US-9353160-B2 · May 31, 2016 · US
Method of prophlactically treating infection using a recombinant fibrinogen binding protein clumping factor A (ClfA) or fragment thereof
US-9353160-B2 · May 31, 2016 · US
Method of prophlactically treating infection using a recombinant fibrinogen binding protein clumping factor A (ClfA) or fragment thereof
US-9353160-B2 · May 31, 2016 · US
Method of prophlactically treating infection using a recombinant fibrinogen binding protein clumping factor A (ClfA) or fragment thereof
US-9353160-B2 · May 31, 2016 · US
Method of prophlactically treating infection using a recombinant fibrinogen binding protein clumping factor A (ClfA) or fragment thereof
US-9353160-B2 · May 31, 2016 · US
Related pages
Navigate to parent entity pages.